NHS National Framework Agreement for the supply of products for the treatment of Bleeding Disorders, including Haemophilia B
key details
| Value | £500,000,000 |
|---|---|
| Status | complete |
| Category (CPV) | 33141530 |
| Deadline | 14 Feb 2022 |
| Procedure | open |
| OCID | ocds-h6vhtk-030881 |
Awards (8)
This procurement was awarded to 8 suppliers. Values shown are per-award; the notice total is £500,000,000.
| Supplier | Value | Date | Status |
|---|---|---|---|
| Bio Products Laboratory Ltd shared | · | · | active |
| CSL Behring UK Ltd shared | · | · | active |
| LFB shared | · | · | active |
| Novo Nordisk shared | · | · | active |
| Octapharma Limited shared | · | · | active |
| Pfizer Ltd shared | · | · | active |
| Sobi (Swedish Orphan Biovitrum Ltd) shared | · | · | active |
| Takeda UK Ltd shared | · | · | active |
description
National Framework Agreement for the supply of products for the treatment of Bleeding Disorders including Haemophilia B. The framework will commence on 1 July 2022 for a period of 24 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 moths. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the invitation to offer documents for a list of the purchasing points.
notice history
4 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 15 Dec 2021 | Planning (planning) | · | 58917ecb-2584-47aa-b8eb-63f97412452d-494393 |
| 7 Jan 2022 | Contract notice (F02) | Earlier regulations | 000489-2022 |
| 4 Jul 2022 | Contract award notice (F03) | Earlier regulations | 018165-2022 |
| 15 Aug 2023 | Planning (planning) | · | ca573ef4-8378-41c0-a9b7-2f7e07ee97a4-671956 |
more from NHS England
- Urgent Award - haematological screening · £16,202 · 29 Jul 2026
- HSCN-AWS Connectivity Service for Spine · £228,060 · 29 Jul 2026
- Incentive Voucher Provider · £60,000 · 29 Jul 2026
- CRM for NHSE participant/candidate data 26-27 · £56,640 · 28 Jul 2026
- Wayfinder and First Contact Digital Clinical Support 2026-27 · £748,000 · 23 Jul 2026
- Support Services for PPM application · £860,000 · 22 Jul 2026
- Digital Maturity Assessment · 21 Jul 2026
- Integrated Healthcare Services to Haslar Immigration Removal Centre (IRC) · £19,052,186 · 13 Jul 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Purchase of Diathermy · Leeds Teaching Hospitals NHS Trust · £48,000
- Provision of R-Phycoerythrin F(ab)2-specific IgG antibody · Public Health England · £130,000
- NHS Framework Agreement for the supply of Recombinant Factor IX products for the treatment of Haemophilia B · NHS England · £192,000,000
- Provision of R-Phycoerythrin F(ab)2-specific IgG antibody · Public Health England · £44,601
- National Framework Agreement for the supply of Recombinant Factor VIII products for the treatment of bleeding disorders · NHS England · £302,000,000
- HOME DELIVERY OF RECOMBINANT COAGULATION FACTORS FOR HAEMOPHILIA PATIENTS · University Hospitals of North Midlands NHS Trust
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.